---
title: "Evofem Biosciences | 8-K: FY2026 Q1 Revenue: USD 899 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286774708.md"
datetime: "2026-05-18T12:58:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286774708.md)
  - [en](https://longbridge.com/en/news/286774708.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286774708.md)
generator: "portal-rs"
---

# Evofem Biosciences | 8-K: FY2026 Q1 Revenue: USD 899 K

Revenue: As of FY2026 Q1, the actual value is USD 899 K.

EPS: As of FY2026 Q1, the actual value is USD -0.04.

Evofem Biosciences, Inc. announced its financial results for the three months ended March 31, 2026; however, the detailed financial results, including specific revenue, operational metrics, or cash flow figures for this period, are not provided within the text of this filing. 

#### Outlook / Guidance

Evofem Biosciences, Inc. anticipates impacts from COGS reduction initiatives, future sales trends, cost-reduction initiatives, manufacturing efficiencies, and international market expansion. The company also expects to pursue additional financing or other strategic alternatives. It acknowledges significant risks including limited cash resources, dependence on new capital for operations, potential delays in regulatory approvals, and manufacturing and supply chain challenges.

### Related Stocks

- [EVFM.US](https://longbridge.com/en/quote/EVFM.US.md)

## Related News & Research

- [Brady beats top-line and bottom-line estimates; gives FY27 outlook](https://longbridge.com/en/news/297896627.md)
- [Campbell’s Company Non-GAAP EPS of $0.39 in-line, revenue of $2.1B misses by $40M](https://longbridge.com/en/news/297905786.md)
- [Yatsen Holding Non-GAAP EPADS of -$0.16, revenue of $168.3M; gives Q3 outlook](https://longbridge.com/en/news/297759833.md)
- [REG - Union Jack Oil PLC Reabold Resources - Statement regarding Reabold offer](https://longbridge.com/en/news/298036801.md)
- [G Sachs Raises Dell Technologies Inc.  TP to USD570, Reiterates Buy Rating](https://longbridge.com/en/news/297858041.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**